IE33982L - Epoxyethylphosphonic acid derivatives - Google Patents
Epoxyethylphosphonic acid derivativesInfo
- Publication number
- IE33982L IE33982L IE700012A IE1270A IE33982L IE 33982 L IE33982 L IE 33982L IE 700012 A IE700012 A IE 700012A IE 1270 A IE1270 A IE 1270A IE 33982 L IE33982 L IE 33982L
- Authority
- IE
- Ireland
- Prior art keywords
- optionally substituted
- substituted hydrocarbyl
- hydrogen
- acyl
- jan
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 230000002421 anti-septic effect Effects 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 abstract 1
- 108010078777 Colistin Proteins 0.000 abstract 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
- 229930182566 Gentamicin Natural products 0.000 abstract 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 abstract 1
- 229930193140 Neomycin Natural products 0.000 abstract 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 abstract 1
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004104 Oleandomycin Substances 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- 239000004187 Spiramycin Substances 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229930194936 Tylosin Natural products 0.000 abstract 1
- 239000004182 Tylosin Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- 229960003346 colistin Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic secondary amine Chemical class 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229960000318 kanamycin Drugs 0.000 abstract 1
- 229930027917 kanamycin Natural products 0.000 abstract 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 abstract 1
- 229930182823 kanamycin A Natural products 0.000 abstract 1
- 229960005287 lincomycin Drugs 0.000 abstract 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 abstract 1
- 229960004927 neomycin Drugs 0.000 abstract 1
- 229960002950 novobiocin Drugs 0.000 abstract 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 abstract 1
- 229960002351 oleandomycin Drugs 0.000 abstract 1
- 235000019367 oleandomycin Nutrition 0.000 abstract 1
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 abstract 1
- 150000002960 penicillins Chemical class 0.000 abstract 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 abstract 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 abstract 1
- 229960001294 spiramycin Drugs 0.000 abstract 1
- 235000019372 spiramycin Nutrition 0.000 abstract 1
- 229930191512 spiramycin Natural products 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229940040944 tetracyclines Drugs 0.000 abstract 1
- LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 abstract 1
- 229960005041 troleandomycin Drugs 0.000 abstract 1
- 235000019375 tylosin Nutrition 0.000 abstract 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 abstract 1
- 229960004059 tylosin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65848—Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6587—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having two phosphorus atoms as ring hetero atoms in the same ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Paints Or Removers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1282671 Antiseptics MERCK & CO Inc 12 Jan 1970 [17 Jan 1969] 1406/70 Heading A5B [Also in Division C2] A pharmaceutical or antiseptic composition comprises a compound of formula where D is -O- or -NR 4 -, R 4 is optionally substituted hydrocarbyl or hydrogen, and W is optionally substituted hydrocarbyl, optionally containing one or more heteroatoms, Z, is -OR, -SR, -NR 1 R 2 , -OM, -SM or halogen, M is a cation, R is hydrogen, acyl or optionally substituted hydrocarbyl, R 1 and R 2 are hydrogen, optionally substituted hydrocarbyl or acyl or alkoxy, or -NR 1 R 2 is the residue of a cyclic secondary amine, and R 3 is C 1-6 alkyl, benzyl or a metal cation, together with other biologically active ingredients, such as erythromycin, lincomycin, penicillins, streptomycin, novobiocin, tylosin, genta mycin, neomycin, colistin, kanamycin, oleandomycin, triacetyloleandomycin, chloramphenicol, tetracyclines, sulphonamides and spiramycin.
[GB1282671A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79213769A | 1969-01-17 | 1969-01-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33982L true IE33982L (en) | 1970-07-17 |
| IE33982B1 IE33982B1 (en) | 1974-12-30 |
Family
ID=25155909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE12/70A IE33982B1 (en) | 1969-01-17 | 1970-01-06 | Epoxyethylphosphonic acid derivatives |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS4924050B1 (en) |
| AT (1) | AT305307B (en) |
| BE (1) | BE744588A (en) |
| BR (1) | BR6914881D0 (en) |
| CH (1) | CH537952A (en) |
| DE (1) | DE2001898A1 (en) |
| ES (1) | ES375396A1 (en) |
| FR (1) | FR2034474B1 (en) |
| GB (1) | GB1282671A (en) |
| HU (1) | HU164086B (en) |
| IE (1) | IE33982B1 (en) |
| IL (1) | IL33660A0 (en) |
| NL (1) | NL6919668A (en) |
| SE (1) | SE366548B (en) |
| ZA (1) | ZA698785B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4654412B2 (en) * | 2005-04-07 | 2011-03-23 | 独立行政法人産業技術総合研究所 | Process for producing α-epoxyphosphonic acids |
| JP4524404B2 (en) * | 2005-08-19 | 2010-08-18 | 独立行政法人産業技術総合研究所 | Method for producing epoxy group-containing phosphorus compound |
-
1969
- 1969-12-08 BR BR214881/69A patent/BR6914881D0/en unknown
- 1969-12-18 ZA ZA698785A patent/ZA698785B/en unknown
- 1969-12-31 NL NL6919668A patent/NL6919668A/xx unknown
-
1970
- 1970-01-05 IL IL33660A patent/IL33660A0/en unknown
- 1970-01-06 IE IE12/70A patent/IE33982B1/en unknown
- 1970-01-12 GB GB0406/70A patent/GB1282671A/en not_active Expired
- 1970-01-13 ES ES375396A patent/ES375396A1/en not_active Expired
- 1970-01-14 CH CH50070A patent/CH537952A/en not_active IP Right Cessation
- 1970-01-15 HU HUME1169A patent/HU164086B/hu unknown
- 1970-01-16 SE SE00528/70A patent/SE366548B/xx unknown
- 1970-01-16 AT AT40770A patent/AT305307B/en not_active IP Right Cessation
- 1970-01-16 DE DE19702001898 patent/DE2001898A1/en active Pending
- 1970-01-16 FR FR707001578A patent/FR2034474B1/fr not_active Expired
- 1970-01-17 JP JP45004739A patent/JPS4924050B1/ja active Pending
- 1970-01-19 BE BE744588D patent/BE744588A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE33982B1 (en) | 1974-12-30 |
| DE2001898A1 (en) | 1970-07-23 |
| BR6914881D0 (en) | 1973-03-08 |
| JPS4924050B1 (en) | 1974-06-20 |
| SE366548B (en) | 1974-04-29 |
| IL33660A0 (en) | 1970-03-22 |
| FR2034474A1 (en) | 1970-12-11 |
| CH537952A (en) | 1973-06-15 |
| ZA698785B (en) | 1971-07-28 |
| NL6919668A (en) | 1970-07-21 |
| FR2034474B1 (en) | 1973-08-10 |
| ES375396A1 (en) | 1972-05-01 |
| BE744588A (en) | 1970-07-20 |
| GB1282671A (en) | 1972-07-19 |
| AT305307B (en) | 1973-02-26 |
| HU164086B (en) | 1973-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901578T2 (en) | Clarithromycin form 0 crystals | |
| ES480109A1 (en) | Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds. | |
| IE811297L (en) | Macrolide antibiotics | |
| GB1426908A (en) | 1-n--s--alpha-hydroxy-omega-aminoacyl- derivative of amino glycosidic antibiotics | |
| NO830686L (en) | PROCEDURE FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES | |
| IE33982L (en) | Epoxyethylphosphonic acid derivatives | |
| IE37688B1 (en) | O-(substituted)oxime derivatives of hydroxyphthalaldehydic acids methods for their preparation and compositions containing them | |
| GB1444396A (en) | Succinic acid derivatives | |
| GB1415601A (en) | Dihydrobetulinic acid derivatives | |
| GB1347598A (en) | Lincomycin derivatives and the manufacture thereof | |
| GB1112909A (en) | Ergoline derivatives | |
| IE44230L (en) | 1, 3-diaza-bicyclo [3,2, 0] heptane derivatives | |
| GB1203538A (en) | Cubane derivatives | |
| GB1282672A (en) | Epoxyethylphosphonic acid derivatives | |
| IE39885B1 (en) | Diphenylimidazolidines and their pharmaceutical compositons | |
| GB1457950A (en) | Antibacterial compositions | |
| GB1490476A (en) | 6-aminomethylated-3-oxygenated cholest-5-enes | |
| GB1425081A (en) | Antibiotics ws-3442a, b,c,d and e and n-acyl derivatives thereof | |
| ES356167A1 (en) | Tetracycline derivative | |
| GB1421685A (en) | Phenoxyalkanecarboxylic acid derivative the preparation thereof and pharmaceutical compositions containing it | |
| GB1138247A (en) | Oleanolic acid derivatives | |
| GB1409850A (en) | Process for the preparation of amino alcohol acetyl salicylic acid ester | |
| GB1301980A (en) | ||
| GB1327707A (en) | Benzene derivatives | |
| GB884883A (en) | Diamino-5,8-quinoline-quinone derivatives |